Literature DB >> 7205974

I-125 implant of the prostate: a new technique.

P P Kumar, F F Bartone.   

Abstract

Retropubic I-125 implantation of the prostate at the time of suprapubic extraperitoneal pelvic lymphadenectomy is a well-established method of treatment for stages B(2) and early C prostatic cancer. However, there are some technical disadvantages with the retropubic I-125 implant technique, such as inadequate space for proper placement of the needles; bleeding, uncontrollable at times, from the periprostatic venous plexus secondary to insertion of needles into the prostate; and superficial wound infection due to inadvertent puncturing of the bladder and/or rectum by the needles. In this paper the authors describe a new technique which eliminates the technical problems associated with retropubic I-125 implantation of the prostate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205974      PMCID: PMC2552624     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  External beam radiation therapy of primary carcinoma of the prostate.

Authors:  M A Bagshaw; G R Ray; D A Pistenma; R A Castellino; E M Meares
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection.

Authors:  B S Hilaris; W F Whitmore; M Batata; W Barzell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Jul-Aug       Impact factor: 7.038

3.  Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer.

Authors:  J E Fowler; W Barzell; B S Hilaris; W F Whitmore
Journal:  J Urol       Date:  1979-04       Impact factor: 7.450

  3 in total
  1 in total

1.  Iodine 125 interstitial irradiation for localized prostate cancer.

Authors:  P P Kumar; R R Good; F F Bartone
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.